Real-World Evidence of Adjuvant Immunotherapy in Resected Stage III and IV Melanoma Patients: CADIM Trial Final Results. Experience from 2 Tertiary Referral Centers

  1. Morellá Fernández, M.
  2. Balsalobre Yago, J.
  3. Martínez García, J.
  4. Peláez Gutiérrez, M.
  5. López Muñoz, A.
  6. Silvestre Ballesta, A.I.
  7. Sánchez Lafuente, B.
  8. Martínez Martín, I.
  9. Cerezuela Fuentes, P.
Journal:
Actas Dermo-Sifiliograficas

ISSN: 1578-2190 0001-7310

Year of publication: 2024

Type: Article

DOI: 10.1016/J.AD.2024.07.021 GOOGLE SCHOLAR lock_openOpen access editor